Commentary: The Clinical Impact of the C0/D Ratio and the CYP3A5 Genotype on Outcome in Tacrolimus Treated Kidney Transplant Recipients
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Book |
| Published: |
Frontiers Media S.A.,
2021-02-01T00:00:00Z.
|
| Subjects: | |
| Online Access: | Connect to this object online. |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
MARC
| LEADER | 00000 am a22000003u 4500 | ||
|---|---|---|---|
| 001 | doaj_561b5caec0e741a8a5d762080f60c99e | ||
| 042 | |a dc | ||
| 100 | 1 | 0 | |a Gerold Thölking |e author |
| 700 | 1 | 0 | |a Gerold Thölking |e author |
| 700 | 1 | 0 | |a Stefan Reuter |e author |
| 245 | 0 | 0 | |a Commentary: The Clinical Impact of the C0/D Ratio and the CYP3A5 Genotype on Outcome in Tacrolimus Treated Kidney Transplant Recipients |
| 260 | |b Frontiers Media S.A., |c 2021-02-01T00:00:00Z. | ||
| 500 | |a 1663-9812 | ||
| 500 | |a 10.3389/fphar.2021.603345 | ||
| 546 | |a EN | ||
| 690 | |a kidney | ||
| 690 | |a metabolism | ||
| 690 | |a C/D ratio | ||
| 690 | |a tacrolimus | ||
| 690 | |a transplantation | ||
| 690 | |a renal | ||
| 690 | |a Therapeutics. Pharmacology | ||
| 690 | |a RM1-950 | ||
| 655 | 7 | |a article |2 local | |
| 786 | 0 | |n Frontiers in Pharmacology, Vol 12 (2021) | |
| 787 | 0 | |n https://www.frontiersin.org/articles/10.3389/fphar.2021.603345/full | |
| 787 | 0 | |n https://doaj.org/toc/1663-9812 | |
| 856 | 4 | 1 | |u https://doaj.org/article/561b5caec0e741a8a5d762080f60c99e |z Connect to this object online. |